</s><s><s><s> human papillomavirus is a necessary cause of invasive cervical cancer worldwide. 
 this article describes the recommendations of the advisory committee on immunization practices of the u.s. centers for Disease control and prevention (CDC ) for the 9-valent vaccine, recombinant and recombinant, for the first time in the united states, and provides recommendations for the use of this vaccine in the prevention and treatment of cervical cancer and related diseases. the vaccine was approved by the food and drug administration in 2014 and is currently available for use in the us and in europe. </s>